Dr. Carmelo A Crespo , MD
General Practice • Dorado, PR
338 Calle Mendez Vigo
Dorado, PR 006464908
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Carmelo Crespo is listed in NPPES under General Practice.
-
NPI assigned on November 22, 2005; this date does not establish years in practice.
-
Published CMS data list 1,200 Medicare Part D prescriptions, including refills, in 2023.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023. Published rows only; this is not a quality measure.
-
Published Part D records, 2023:
- Atorvastatin Calcium — 114 prescription fills, including refills.
- Alendronate Sodium — 92 prescription fills, including refills.
- Omeprazole — 84 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 37 records in the table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 1,400 in 2019 to 1,200 in 2023.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019–2023.
Practice Location & Contact Primary Location
338 Calle Mendez Vigo
Dorado, PR 006464908
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,290 standardized 30-day fills in 2023
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$27,755 in 2023
The total cost of these prescriptions in 2023, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $71.63 in 2019
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2019.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Crespo has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Crespo as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Dorado and Puerto Rico
Billing and prescribing volume is not a quality rating.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Crespo are from 2023.
44 active clinicians are listed under General Practice with a practice address in Dorado, PR (4,225 in Puerto Rico).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Dorado
2.3% of these 44 clinicians have the CMS telehealth indicator.
27.3% of these 44 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 14% from 1,400 in 2019 to 1,200 in 2023.
- 2019: 1,400
- 2020: 1,523
- 2021: 1,611
- 2022: 1,999
- 2023: 1,200
-
30-day fills
30-day fills decreased 24% from 3,007 in 2019 to 2,290 in 2023.
- 2019: 3,007
- 2020: 3,380
- 2021: 3,379
- 2022: 3,877
- 2023: 2,290
-
Part D drug cost
Part D drug cost decreased 41% from $47,328 in 2019 to $27,755 in 2023.
- 2019: $47,328
- 2020: $42,821
- 2021: $44,918
- 2022: $70,408
- 2023: $27,755
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2019 only.
Sources: CMS Medicare Part D Prescribers (2023), CMS Open Payments (2019), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2019 (payments made January 1 – December 31, 2019): fewer than 11 records totaling $71.63.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Merck Sharp & Dohme Corporation |
Food and Beverage
In-kind items and services
|
RENFLEXIS | General | $71.63 |
Source: CMS Open Payments, program year 2019, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2023.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 114 | 9,480 | $1,493.10 | 54 |
| Alendronate Sodium | Alendronate Sodium | 92 | 3,456 | $499.30 | 24 |
| Omeprazole | Omeprazole | 84 | 2,638 | $514.01 | 23 |
| Lisinopril | Lisinopril | 78 | 5,880 | $480.51 | 34 |
| Gabapentin | Gabapentin | 63 | 4,470 | $958.69 | 25 |
| Pantoprazole Sodium | Pantoprazole Sodium | 58 | 1,740 | $283.22 | 11 |
| Metformin Hcl | Metformin Hcl | 49 | 3,630 | $272.33 | 18 |
| Famotidine | Famotidine | 49 | 1,440 | $432.47 | 15 |
| Synthroid | Levothyroxine Sodium | 46 | 3,540 | $5,412.21 | 17 |
| Nabumetone | Nabumetone | 39 | 689 | $405.93 | 19 |
| Amlodipine Besylate | Amlodipine Besylate | 32 | 2,880 | $168.97 | 17 |
| Montelukast Sodium | Montelukast Sodium | 32 | 1,045 | $299.74 | 15 |
| Furosemide | Furosemide | 31 | 1,972 | $156.56 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 31 | 2,190 | $128.90 | 13 |
| Tamsulosin Hcl | Tamsulosin Hcl | 31 | 2,010 | $298.43 | 12 |
| Metformin Hcl Er | Metformin Hcl | 28 | 2,340 | $306.88 | 13 |
| Latanoprost | Latanoprost | 28 | 801 | $244.73 | — |
| Metoprolol Tartrate | Metoprolol Tartrate | 26 | 1,620 | $198.14 | — |
| Ibuprofen | Ibuprofen | 26 | 362 | $100.66 | — |
| Losartan Potassium | Losartan Potassium | 26 | 2,340 | $640.43 | 11 |
| Glipizide Er | Glipizide | 20 | 1,800 | $853.01 | — |
| Simvastatin | Simvastatin | 19 | 1,470 | $187.90 | — |
| Glipizide | Glipizide | 18 | 1,620 | $168.22 | — |
| Fluticasone Propionate | Fluticasone Propionate | 16 | 570 | $202.22 | — |
| Sulindac | Sulindac | 15 | 251 | $140.52 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2023; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
NUCC Taxonomy Code: 207P00000X
An emergency physician focuses on the immediate decision making and action necessary to prevent death or any further disability both in the pre-hospital setting by directing emergency medical technicians and in the emergency department. The emergency physician provides immediate recognition, evaluation, care, stabilization and disposition of a generally diversified population of adult and pediatric patients in response to acute illness and injury.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GENERAL PRACTICE
I20100729000421
PR
6002949930
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History
NPI enumerated November 22, 2005.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other General Practices in Dorado
- Dr. Evans Ortiz Santana, MD
- Dr. Fausto Lugo Morales, MD
- Dr. Elham Ghorbani, MD
- Dr. Rigoberto Gonzalez Jimenez, MD
- Dr. Blanca Plaza, MD
- Carlos Robles
Mailing Address
Po Box 687
Dorado, PR 006460687
Phone: 7877963466